Page last updated: 2024-08-26

1,3,4-oxadiazole and Parkinson Disease

1,3,4-oxadiazole has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, YL; Duan, YJ; Li, QS; Liu, ZG; Meng, HW; Meng, XS; Shen, ZB; Wang, TX; Wang, XR; Yang, XX; Yin, ZQ; Zhang, S; Zou, TF	1

Other Studies

1 other study(ies) available for 1,3,4-oxadiazole and Parkinson Disease

Article	Year
Novel flavonoid 1,3,4-oxadiazole derivatives ameliorate MPTP-induced Parkinson's disease via Nrf2/NF-κB signaling pathway. Bioorganic chemistry, 2023, Volume: 138 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Flavonoids; Inflammation; Mice; Mice, Inbred C57BL; Neuroprotective Agents; NF-E2-Related Factor 2; NF-kappa B; Parkinson Disease; Signal Transduction	2023

Article

Year

Novel flavonoid 1,3,4-oxadiazole derivatives ameliorate MPTP-induced Parkinson's disease via Nrf2/NF-κB signaling pathway.

Bioorganic chemistry, 2023, Volume: 138

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Flavonoids; Inflammation; Mice; Mice, Inbred C57BL; Neuroprotective Agents; NF-E2-Related Factor 2; NF-kappa B; Parkinson Disease; Signal Transduction

2023